古塞库单抗治疗合并克罗恩病的化脓性汗腺炎患者：有效性和安全性的病例报告及系统文献综述
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety.
作者信息
Jørgensen Astrid-Helene Ravn, Holm Jesper Grønlund, Thomsen Simon Francis
机构信息
Department of Dermato-Venereology & Wound Healing Centre Bispebjerg Hospital Copenhagen Denmark.
Department of Biomedical Sciences University of Copenhagen Copenhagen Denmark.
出版信息
Clin Case Rep. 2020 Sep 10;8(12):2874-2877. doi: 10.1002/ccr3.3090. eCollection 2020 Dec.
Abstract
Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
摘要
古塞库单抗在治疗对阿达木单抗和其他全身疗法无反应的化脓性汗腺炎患者中似乎是安全有效的。古塞库单抗可用于合并克罗恩病的患者。
Zotero 插件